Insomnia, causes and treatments. Scientific meeting of the Turin Academy of Medicine
Food crisis Syria and Yemen, 30 million mouths to feed. Oxfam appeal
April 4, 2022
New GMOs. Petition against deregulation
April 17, 2022
Insomnia reduces the quality of life and generates, in a cascade, health problems, worsening health care costs, absence from work and lower productivity. The Turin Academy of Medicine dedicates the scientific meeting to the topic 'Insomnia. Pathophysiological and therapeutic aspects', also accessible online, Friday 8.4.22, at 17.30.
Insomnia, the meeting at the Turin Academy of Medicine
The he was introduced by Roberto Mutani, professor emeritus of Neurology and member of the Academy of Medicine.
Speakers the speakers Alessandro Cicolin, head of the Regional Reference Center for Sleep Disorders, Molinette Hospital in Turin, and Luigi Ferini-Strambi, full professor of Neurology and director of the Sleep Medicine Center, Vita-Salute University of San Raffaele in Milan .
Day and night symptoms
According to Alessandro Cicolin, insomnia represents the most common sleep disorder and is characterized by the presence of nocturnal symptoms (difficulty falling asleep and staying asleep) and diurnal symptoms (fatigue, depression of mood, general malaise, cognitive difficulties).
Recent advances in understanding the pathophysiology of insomnia, they significantly changed the therapeutic approach from both a pharmacological and psychological point of view.
We need a diagnostic picture
The professor. Luigi Ferini-Strambi believes that before initiating treatment for insomnia, a precise diagnostic setting is essential. This is important, for example, for situations where insomnia is linked to a depressive disorder or restless legs syndrome.
According to the guidelines internationals, the treatment of first choice for insomnia is that of cognitive-behavioral therapy. It is certainly an effective therapy, but not easily accessible, since there are few centers in Italy where it is performed.
New drugs on the way
Misc are the options for choosing drug treatment. The basic rule is to avoid drugs with a long half-life and to use the minimum doses necessary.
In addition to hypnotics benzodiazepics (such as triazolam and brotizolam) and Z-drugs (such as zolpidem and eszopiclone), compounds with a new mechanism of action will soon be available: the antagonists of orexin, a neurotransmitter involved in promoting wakefulness.
How to participate
In order to participate at the scientific meeting in the presence, at the Aula Magna of the Academy of Medicine of Turin (via Po 18, Turin), it is necessary to book by email at the address [email protected] and the presentation of the Green Pass.
The it is also open to remote participation, through the site www.accademiadimedicina.unito.it.
